Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar;55(3):228-230.
doi: 10.4070/kcj.2024.0402.

Is Lower-Dose Edoxaban Sufficiently Effective and Safe for the Treatment of Korean Patients With Atrial Fibrillation?

Sung Il Im  1
Affiliations
Editorial

Is Lower-Dose Edoxaban Sufficiently Effective and Safe for the Treatment of Korean Patients With Atrial Fibrillation?

Sung Il Im. Korean Circ J. 2025 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author has no financial conflicts of interest.

Comment on

References

    1. Writing Committee Members. Joglar JA, Chung MK, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83:109–279. - PMC - PubMed
    1. Kato ET, Giugliano RP, Ruff CT, et al. Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. J Am Heart Assoc. 2016;5:e003432. - PMC - PubMed
    1. Wang KL, Lopes RD, Patel MR, et al. Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials. Eur Heart J. 2019;40:1492–1500. - PubMed
    1. Kim JY, Choi EK, Lim HE, Oh YS, Cho Y, On YK. Outcomes of on-label reduced-dose edoxaban in patients with atrial fibrillation: the LEDIOS registry. J Korean Med Sci. 2022;37:e335. - PMC - PubMed
    1. Lip GY, Wang KL, Chiang CE. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal. Int J Cardiol. 2015;180:246–254. - PubMed

Publication types

LinkOut - more resources